Clinical Phase IIb Study Of ATH008 In Hand-Foot Syndrome (Palmar-Plantar Erythrodysesthesia Syndrome)
Friday, April 22, 2011 - 18:40
in Psychology & Sociology
ADVANCELL has initiated a phase IIb clinical study of the Company's ATH008, for the treatment of the palmar-plantar erythrodysesthesia syndrome, also known as hand-foot syndrome, a painful side-effect of certain chemotherapies such as capecitabine and fluoropyrimidines. No treatment currently exists for this condition. ADVANCELL expects to launch the product on the market by the end of 2015 or beginning of 2016. read more
